Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation.
about
Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitusCD36: implications in cardiovascular diseaseEmerging role of mast cells and macrophages in cardiovascular and metabolic diseasesATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation.Murine 12/15-lipoxygenase regulates ATP-binding cassette transporter G1 protein degradation through p38- and JNK2-dependent pathways.An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells.12/15-Lipoxygenase activity increases the degradation of macrophage ATP-binding cassette transporter G1.Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneysAdenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice.High-density lipoprotein and atherosclerosis: Roles of lipid transporters.Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA.Regulation of ATP-binding cassette transporters and cholesterol efflux by glucose in primary human monocytes and murine bone marrow-derived macrophagesRAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes.Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice.Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis.High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes.ABC transporter genes and risk of type 2 diabetes: a study of 40,000 individuals from the general population.Disordered haematopoiesis and athero-thrombosis.Emerging new paradigms for ABCG transporters.Renal dysfunction potentiates foam cell formation by repressing ABCA1.Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages.Monocyte and macrophage dynamics during atherogenesis.Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.Potential effect of ezetimibe against Mycobacterium tuberculosis infection in type II diabetes.Critical Role of the Human ATP-Binding Cassette G1 Transporter in Cardiometabolic Diseases.High glucose, unsaturated and saturated fatty acids differentially regulate expression of ATP-binding cassette transporters ABCA1 and ABCG1 in human macrophages.High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance.Caveolin gene transfer improves glucose metabolism in diabetic mice.Oral nicotine aggravates endothelial dysfunction and vascular inflammation in diet-induced obese rats: Role of macrophage TNFα.ABCG1 deficiency promotes endothelial apoptosis by endoplasmic reticulum stress-dependent pathway.Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk.
P2860
Q24314471-BFE0463A-5492-4C02-905B-DFB0B85DC2CFQ24678338-39000A9B-ADC7-4CFE-BF16-FA9C72E456DEQ26825467-A5015408-9F4D-461C-B59E-4831625F21EDQ30427703-7CDF8D22-A994-4188-896B-ACA1BD134326Q30434202-7EFA7F40-00E0-4370-8625-5EC375034239Q30435561-C1F31BD5-0B43-4442-84B9-A760E829C1FFQ30438268-2E4DED36-AABD-4D86-BF37-8F684B8F4250Q33901965-6190AEC8-9442-4105-A3D4-8818E73EF231Q34236808-C205F70E-9DCE-48C5-8135-5007B701A18AQ34404454-CED337C6-71BE-4B6A-8D90-5B7DD6CD4621Q34545552-7743075E-6FA3-4AE0-8E44-C199BBC32FDDQ34788340-DF252DA1-37B5-4A0A-98B6-C6F862842BD6Q35740332-CB208639-9282-478B-B20B-A1DFCF1C62BBQ35852679-10AE07FF-6C41-474B-B367-3F06772C29CBQ35903021-55D176A7-EE93-42B0-82D7-D8208ECCB23BQ36335099-9AE88244-3810-4A98-860B-F0297E668E5BQ36426889-F1C7F877-4233-4337-8B54-1057855367C6Q36773876-213E13B3-FFE6-4B5D-8445-C84D84733BF5Q37233815-9F802822-7339-43AC-A035-074D2F57F838Q37357219-650FC5E8-08E3-4C31-BD2D-2D60602D64F9Q37386332-3FDE5430-CCBC-45B8-85E9-AE8388B9D755Q37890185-BBF915A6-6CEF-424E-B6F0-42BED5551198Q38831558-9231BA84-2FA1-4A60-B888-9538266AB763Q40438875-404105A7-D32E-4E41-A322-E1DF3A6E0709Q41661037-78F92EB8-EFF1-401D-8D34-8994C1FD41C3Q43131697-81D064AB-6693-4E4E-848F-FAC360EA4BE2Q43223219-6C54C33A-95A5-4402-BEA9-3BC1E0727955Q43239272-9840DB6D-6386-495B-A12E-CFCC28AAEAE5Q47139547-902FD75A-94BE-43EF-A636-212CE6BE33A5Q47905737-7B3D1A48-569A-46CD-9196-EDC2DC56725DQ50021708-DACA376B-0587-489A-B766-FE91EAA7E759
P2860
Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation.
@ast
Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation.
@en
type
label
Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation.
@ast
Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation.
@en
prefLabel
Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation.
@ast
Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation.
@en
P2093
P2860
P356
P1476
Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation.
@en
P2093
Abraham Gebre
Alan Daugherty
Anny Mulya
Catherine C Hedrick
Jeremy P Mauldin
John S Parks
Suseela Srinivasan
P2860
P304
21216-21224
P356
10.1074/JBC.M510952200
P407
P577
2006-05-24T00:00:00Z